Canada Must Prepare for Oil Shocks and Shortages

Canada’s healthcare system faces mounting pressure from oil price volatility, with costs potentially adding between one and 12 billion dollars annually depending on market conditions. The impact extends far beyond energy bills, threatening supply chains for essential medications and medical supplies that hospitals depend on daily.

At 200 dollars per barrel, provinces could face an additional three to five billion dollars in energy expenses to run healthcare facilities. Experts warn this would force provincial governments to cut services, potentially leading to preventable disability and deaths unless the federal government provides emergency transfer payments.

Logistics of patient care face equally serious disruptions. Travel costs for doctors and nurses would soar, while Medevac expenses could double. Rural and northern communities would bear the brunt of these increases, with some services potentially requiring federal subsidies to remain viable.

Pharmaceutical supply chain vulnerabilities

Approximately 95 per cent of all medications are synthesized from petrochemicals derived from petroleum. More than 80 per cent of active pharmaceutical ingredients come from China and India, both major oil importers facing the same global market pressures. Generic drug prices could rise by 30 to 50 per cent under these conditions.

The implications reach well beyond prescription medications. Roughly 70 per cent of all medical consumables, including gloves, syringes, IV tubing, gowns, and wound dressings, are manufactured from petrochemical-derived plastics and polymers. The cold chain infrastructure that keeps biologics, vaccines, and blood products viable during transport also depends on diesel-powered distribution networks.

Canada, where insulin was discovered, currently has no domestic manufacturing capacity for the drug. Beyond insulin, common blood pressure medications, cancer drugs, and antibiotics face similar supply vulnerabilities. The document notes that the pharmaceutical supply chain represents the healthcare system’s most acute and least understood oil shock risk.

The broader economic consequences of oil shocks create additional strain on population health. When people cannot afford healthy food or medications, they become more likely to require acute healthcare services, creating a self-amplifying cycle of demand and cost.

Proposed policy responses

Policy researchers suggest several measures to build resilience. A 90-day national reserve of essential consumables, modeled on existing petroleum reserve frameworks, could be held at regionally distributed warehouses. Federal investment in domestic manufacturing capacity for gloves, gowns, and IV bags would reduce reliance on imported supplies vulnerable to global disruptions.

Additional proposals include a federal fund of 500 to 750 million dollars for heat pump conversion at healthcare facilities, emergency operating subsidies for rural hospitals serving populations under 10,000, and enhanced travel subsidies for medical personnel. A national group-purchasing organization could pool provincial procurement during declared supply shocks, maximizing negotiating leverage and ensuring equitable distribution.

Redundancy in cold chain infrastructure, with multiple regional storage sites for temperature-sensitive products, would add another layer of protection against localized disruptions.

Some of these costs are unavoidable. The logistics challenges cannot be wished away. However, a substantial portion remains preventable through actions available now, at costs that are significant but ultimately fractional compared to what they would prevent.

The 180-day drug stockpile costing a billion today pales against the consequences of a global insulin shortage affecting nearly four million Canadians with diabetes. The rural hospital emergency fund at 500 million dollars annually could prevent loss of healthcare access for millions of Canadians who have no alternative providers nearby.